GlassScriptPhysician profile
Melvin Douglas Russell
NPI 1760452999
$3,528.79
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $3,055 · 2021: $233 · 2022: $53.36.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,795.30 | 2020 | |
| Abbvie INC. | $210.46 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.51 | 2019-2021 | |
| Allergan, INC. | $71.76 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $71.10 | 2019-2020 | |
| Eisai INC. | $62.50 | 2020-2021 | |
| Mylan Specialty L.P. | $43.54 | 2020 | |
| Pfizer INC. | $38.32 | 2019-2021 | |
| Boston Scientific Corporation | $36.08 | 2019 | |
| Amarin Pharma, INC. | $20.26 | 2019 | |
| Amgen INC. | $19.20 | 2019 | |
| Vanda Pharmaceuticals INC. | $19.19 | 2020 | |
| Adlon Therapeutics L.P. | $16.37 | 2020 | |
| Janssen Pharmaceuticals, INC | $16.25 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.91 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $12.04 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melvin Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.